Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo

M.H. Vingerhoeds, P.A. Steerenberg, J.J.G.W. Hendriks, L.C. Dekker, Q.G.C.M. van Hoesel, D.J.A. Crommelin, G. Storm

    Research output: Contribution to journalArticleAcademicpeer-review

    67 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1023-1029
    JournalBritish Journal of Cancer
    Volume74
    DOIs
    Publication statusPublished - 1996

    Keywords

    • Doxorubicin
    • Immunoliposome
    • Monoclonal antibody
    • Ovarian cancer
    • Targeted drug delivery

    Cite this